Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Sprint Bioscience AB

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 5,715 Less Arrow 4,550 Less Arrow 7
Financial expenses 3 More Arrow 35 Less Arrow 0
Earnings before taxes -1,591 More Arrow -39 Less Arrow -5,407
EBITDA -1,629 More Arrow -36 Less Arrow -5,403
Total assets 3,661 More Arrow 5,622 Less Arrow 3,363
Current assets 3,242 More Arrow 5,216 Less Arrow 3,135
Current liabilities 2,854 More Arrow 3,119 Less Arrow 830
Equity capital 807 More Arrow 2,503 More Arrow 2,533
- share capital 608 More Arrow 629 Less Arrow 627
Employees (average) 37 Less Arrow 28 More Arrow 34

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 22.0% More Arrow 44.5% More Arrow 75.3%
Turnover per employee 154 More Arrow 162 Less Arrow 0
Profit as a percentage of turnover -27.8% More Arrow -0.9% Less Arrow -77242.9%
Return on assets (ROA) -43.4% More Arrow -0.1% Less Arrow -160.8%
Current ratio 113.6% More Arrow 167.2% More Arrow 377.7%
Return on equity (ROE) -197.1% More Arrow -1.6% Less Arrow -213.5%
Change turnover 1,319 More Arrow 4,542 Less Arrow -3,148
Change turnover % 30% More Arrow 60725% Less Arrow -100%
Chg. No. of employees 9 Less Arrow -6 More Arrow 3
Chg. No. of employees % 32% Less Arrow -18% More Arrow 10%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.